Insiders Johnson & Johnson Buenos Aires S.E.

Equities

End-of-day quote Buenos Aires S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
13,162 ^ARS	+0.84%		+4.63%	+29.87%

06-28	Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial	MT
06-28	J&J Unit's Rybrevant Combo Gets EU Approval	MT

Valneva Names New Chief Scientific Officer	05-21	MT
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	04-16	MT
Clearside Biomedical Names Victor Chong Chief Medical Officer	03-18	MT
Johnson & Johnson Insider Sold Shares Worth $1,441,765, According to a Recent SEC Filing	03-13	MT
LivaNova Names Vladimir Makatsaria as Chief Executive	02-05	MT
Joseph Wolk, CFO of J&J: End of patent for its flagship drug	01-23	MT
Johnson & Johnson Names Eugene Woods as Board Member	11-30	DJ
Johnson & Johnson Appoints Eugene A. Woods to its Board of Directors	11-30	CI
Johnson & Johnson Announces Executive Changes	23/10/23	CI
Biomea Fusion Names Juan Pablo Frias as Chief Medical Officer, Steve Morris to Become Chief Development Officer	31/08/23	MT
Top Stories at Midday: Yellow Calls it Quits; JNJ Unit Loses Second Bid at Bankruptcy; JB Hunt Buys Nikola Trucks, Walmart Raises Flipkart Stake	31/07/23	MT
Insider Sell: Johnson & Johnson	27/07/23	MT
Insider Sell: Johnson & Johnson	27/07/23	MT
INTERVIEW - Joseph Wolk, Johnson & Johnson: inflation law may hamper innovation	20/07/23	MT
Idorsia's Commercial Chief to Step Down	30/05/23	MT
Nyxoah Appoints Chief Commercial Officer	11/05/23	MT
Johnson & Johnson Announces the Retirement of Ian E. L. Davis as Director	03/04/23	CI
STAAR Surgical Appoints Warren Foust as Chief Operating Officer	29/03/23	MT
Insider Sell: Johnson & Johnson	08/03/23	MT
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to Its Board of Directors	14/02/23	CI

No results for this search

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 05:30 pm